Healthcare Data Monetization Market Poised to Reach $1.3 Billion by 2031

The sector is undergoing a fundamental transformation, moving away from simple, static data licensing toward integrated, AI-driven ecosystems. Pharmaceutical companies, payers, and research organizations are increasingly hungry for enriched datasets that combine clinical notes, genomic information, and real-world evidence. This shift is powered by the rapid adoption of electronic health records and the deployment of cloud-based platforms that provide the scalability required to process massive, complex information flows.

Strategic partnerships are currently defining the competitive landscape. Recent moves, such as the collaboration between Inovalon and OMNY Health or Regeneron’s multi-million dollar investment in longitudinal EHR access, highlight how firms are prioritizing interoperability and privacy-preserving data linkage. North America remains the dominant revenue driver, bolstered by a robust investment climate and regulatory frameworks that encourage data secondary use. As tech giants like Google and Microsoft deepen their footprint in the clinical space, the market is becoming increasingly defined by those who can provide not just raw data, but actionable, AI-ready insights.